These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Beta-adrenergic treatment of C6 glioma cells produces opposite changes in c-fos and c-jun mRNA levels. Gubits RM, Yu H. J Neurosci Res; 1991 Dec; 30(4):625-30. PubMed ID: 1686282 [Abstract] [Full Text] [Related]
3. Possible involvement of 5alpha-reduced neurosteroids in adrenergic and serotonergic stimulation of GFAP gene expression in rat C6 glioma cells. Morita K, Arimochi H, Itoh H, Her S. Brain Res; 2006 Apr 26; 1085(1):49-56. PubMed ID: 16581042 [Abstract] [Full Text] [Related]
4. Stimulation of nerve growth factor mRNA content in C6 glioma cells by a beta-adrenergic receptor and by cyclic AMP. Schwartz JP. Glia; 1988 Apr 26; 1(4):282-5. PubMed ID: 2853697 [Abstract] [Full Text] [Related]
5. Characterization of C6-10A glioma cells highly responsive to beta-adrenergic receptor agonist-induced NGF synthesis/secretion. Fukumoto H, Kakihana M, Suno M. Glia; 1994 Oct 26; 12(2):151-60. PubMed ID: 7532621 [Abstract] [Full Text] [Related]
9. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis. Zaremba TG, Fishman PH. Mol Pharmacol; 1984 Sep 26; 26(2):206-13. PubMed ID: 6207420 [Abstract] [Full Text] [Related]
10. Induction of nerve growth factor responsiveness in C6-2B glioma cells by expression of trkA proto-oncogene. Colangelo AM, Fink DW, Rabin SJ, Mocchetti I. Glia; 1994 Oct 26; 12(2):117-27. PubMed ID: 7868185 [Abstract] [Full Text] [Related]
15. Synergistic effect of dexamethasone and beta-adrenergic receptor agonists on the nerve growth factor gene transcription. Colangelo AM, Mallei A, Johnson PF, Mocchetti I. Brain Res Mol Brain Res; 2004 May 19; 124(2):97-104. PubMed ID: 15135217 [Abstract] [Full Text] [Related]
20. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade. Neve KA, Molinoff PB. Mol Pharmacol; 1986 Aug 19; 30(2):104-11. PubMed ID: 3016496 [Abstract] [Full Text] [Related] Page: [Next] [New Search]